PF-03814735

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-03814735, covering 2012-06-12 to 2012-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors [Phase 1]